ACOG Releases 2026 Maternal Immunization Schedule - Summary - MDSpire

ACOG Releases 2026 Maternal Immunization Schedule

Thirteen other organizations endorsed guidance that extends across pregnancy, postpartum care, and lactation.

  • By

  • Kerri Miller

  • June 12, 2026

  • 3 min

Share

Objective:

To provide guidance for maternal immunizations for pregnant, postpartum, and lactating patients in the US.

Approach:
    Key Findings:
    • Influenza vaccination is recommended before the end of October and at any time during the influenza season.
    • COVID-19 vaccination is encouraged as soon as possible during any trimester.
    • A Tdap dose is recommended during each pregnancy at 27-36 weeks of gestation.
    • Only Pfizer’s Abrysvo is recommended for maternal RSV vaccination, ideally between 32-36 weeks of gestation.
    Interpretation:

    The schedule serves as a tool for healthcare providers to discuss the importance of immunizations with patients.

    Limitations:
    • The schedule is not inclusive of all treatments or methods of care.
    • It may not reflect the most recent evidence as it is reviewed regularly.
    Conclusion:

    The ACOG maternal immunization schedule aims to enhance maternal and infant health through vaccination.

    Sources:

Original Source(s)

ACOG Releases 2026 Maternal Immunization Schedule

  • by Kerri Miller

  • June 12, 2026

Related Content

Iron Deficiency Guidance Varies in Premenopausal Women

A Beyond the Guidelines discussion highlighted uncertainty around gastrointestinal evaluation and intravenous iron use in premenopausal women with iron deficiency.

Online Menopause Information–Seeking Search Patterns and Commercial Content Over 2 Decades

Higher-Dose Prenatal Vitamin D Linked to Memory Scores

Children exposed to higher-dose prenatal vitamin D scored modestly higher on verbal and visual memory tests at age 10 years, although overall intelligence and most cognitive measures did not differ significantly.